Our growth strAtegy

Our future growth will be achieved by focusing on the following key areas:


Increasing sales of existing commercial products

We intend to drive revenue in the short term in our Commercial business, focusing on Harpin αβ.

We plan to grow in crops where Harpin αβ provides the most benefits to farmers, including sugarcane, corn, soy, citrus, tomatoes and potatoes.


Launching peptide products from our PREtec platforms both through technology licences and in direct sales to distributors

Our partners have been evaluating our peptide platforms since 2015. With registration submitted in the USA and strong progress on manufacturing processes, we anticipate launches from 2021 onwards. We are targeting markets with a value of over $5 billion.


Building further the capability to deliver further products from PREtec

Plant Health Care has a unique understanding of PREtec, which will be important for evaluating and developing peptide products from our platforms. Our capacity to develop cost-effective production processes and our skill in achieving fast-track registrations will enable our partners to accelerate market launches. Our unique understanding of plant response elicitors will enable us to mine our platforms for further peptides over time.


Continuing to develop further peptide platforms

We expect to discover more platforms over time.